- The health group signs an agreement with the International Breast Cancer Center so that its patients can access clinical trials, innovative drugs and national and international translational research projects led by Dr. Cortés
- The Ribera group's Breast Area is already a benchmark in technology, Radiology, Pathology and Oncoplastic Surgery with its contrast-enhanced 3D mammographs, rapid breast biopsies, genetic signature, conservative surgery and nipple tattooing.
Valencia, 16 of September 2021 – The Ribera health group and the International Breast Cancer Center (IBCC) in Barcelona have signed an agreement to incorporate the experience and knowledge of the team of oncologists and researchers led by Dr. Javier Cortés to the Ribera Breast Area, which Directed by Dr. Julia Camps. Thanks to this strategic alliance, patients with breast cancer at the Ribera hospitals will be evaluated by the tumor committee by the IBCC professionals, who have already joined the multidisciplinary team of the Breast Area, and will have access to the trials clinics, innovative drugs and translational research projects, national and international, led by Dr. Cortes.
The IBCC is the first hyper-specialized center in Spain for the treatment of breast cancer, promoted by Dr. Javier Cortés and his team, conceived from a global, humanistic and scientific approach, to which more than 20 years of experience in research are added. and the treatment of breast cancer.
The Breast Area of the Ribera group is already a benchmark in technology, Radiology, Pathology and Oncoplastic Surgery and brings together fifty professionals from different specialties, with more than 20 years of experience in breast pathology. Their work is based on the knowledge shared through the breast committees of the different hospitals (transversal), providing patients with personalized care and the best specialists to jointly assess each case. Working in a network from the different hospitals of the Ribera group, it provides its patients with innovative technology, such as its contrast-enhanced 3D mammographs, pioneering techniques such as rapid breast biopsy and genetic signature in the initial biopsy, as well as precision surgical approaches, support emotional and nipple tattoo, among others.
“The addition of the knowledge and experience of the IBCC and the team of Dr. Cortés to the Breast Area of the Ribera group is a milestone that allows us to provide our patients with hyper-specialized, innovative and cutting-edge care in the diagnosis and treatment of this pathology” explains Dr. Julia Camps, corporate head of the Breast Area, who added that "ours has been a natural alliance". "We are the perfect partners, we share philosophy and values, a vocation for service and excellence, experience, involvement, professionalism, avant-garde and innovation", assured Dr. Camps, who recalled that personalized care and support for patients, as well as precision medicine (opportune treatment, at the precise moment) is key for both entities.
For his part, Dr. Javier Cortés affirms that “I think it is a great opportunity for everyone, for the IBCC, which specializes exclusively in breast cancer; for the Ribera group; and, ultimately, for the patients of this cancer”.
Dr. Cortés highlights that "Ribera is a very serious group in patient care, in the logistics of patient care, so that they are well cared for, really, and that they have the best imaging strategies, rapid diagnosis and Furthermore, of quality" and adds that "if you ask me why with Ribera, I answer that because they have made a firm commitment to breast pathology and because the person who directs and coordinates this area is Julia Camps, objectively recognized as one of the the world's highest authorities in magnetic resonance imaging of the breast, together with a team of brilliant professionals”.
Therefore, "by combining the efforts of the two groups and optimizing the best of each, we believe that we can become leaders in Spain from the point of view of both care and clinical research, at least in breast cancer, for now" , emphasizes Dr. Cortés.
